They received 12 mg once weekly retatrutide injections subcutaneously for 12 weeks
Depression and diabetes also share sociodemographic and lifestyle risk factors
Recent Phase 3 data showed average weight reduction exceeding 28% in some participant groups after extended treatment periods
The copay also isnt eligible for the Medicare Prescription Payment Plan, which lets beneficiaries spread their out-of-pocket drug costs throughout the calendar year
Hair loss during weight-loss medication treatment is more common than many patients expect
Concomitant antidiabetic therapies were frequently reported, with metformin being the most frequently reported concomitant medication (n = 1,879), followed by pioglitazone (n = 478), insulin glargine (n = 474), glipizide (n = 467), and glimepiride (n = 345) (Figure S1)